Email This Release
Celltrion收到CHMP對首批推薦用於治療新冠肺炎的單株抗體之一regdanvimab (CT-P59)的肯定意見
*
marks required fields
Recipient Name:
*
Recipient Email:
Message:
*
Enter security words: